Table 2.
Effect of APDT, antibiotic resistance and susceptibility to increased exposure to antibiotics among bacterial strains isolated from patients diagnosed with diabetic foot ulcers.
| No. | Bacterial species (PCM numer) | Antibiotic resistance | Susceptible, increased exposure | Effect of APDT (reduction log) |
|---|---|---|---|---|
| 1 | Staphylococcus aureus (3047) MRSA, MLSB (constitutive) | Amikacin, carbapenems, cephalosporins, cipro*, levo**, clindamycin, cloxacillin, erythromycin, lincosamides, macrolides, penicillins, streptogramins b, tobramycin | – | 5 |
| 2 | S. aureus (3048) MSSA | – | Cipro*, levo** | No data |
| 3 | S. aureus (3084) MSSA | Amikacin, cipro*, levo**, tobramycin | – | No data |
| 4 | S. capitis (3064) CoNS MSCNS | – | Cipro*, levo** | 5.2 |
| 5 | S. caprae (3063) CoNS MSCNS | Amikacin, gentamicin, tobramycin | Cipro*, levo** | 3 |
| 6 | S. caprae (3185) CoNS MSCNS, MLSB (constitutive) | Amikacin, clindamycin, erythromycin, macrolides, gentamicin, lincosamides, streptogramins b, tobramycin | Cipro*, levo** | No data |
| 7 | S. cohnii (3186) MSCNS | – | Cipro*, levo** | 2.9 |
| 8 | S. epidermidis (3068) CoNS MSCNS | – | Cipro*, levo** | 5.4 |
| 9 | S. haemolyticus (3061) CoNS MRCNS, MLSB (constitutive) | Carbapenems, cephalosporins, clindamycin, erythromycin, methicillin, penicillins, tetracycline | Cipro*, levo** | 2.6 |
| 10 | S. hominis (3060) CoNS MSCNS, MLSB (inducible) | Amikacin, clindamycin, erythromycin, tetracycline, tobramycin | Cipro*, levo** | > 8 |
| 11 | S. pasteuri (3062) CoNS MSCNS | Erythromycin, tetracycline | Cipro*, levo** | 6.6 |
| 12 | S. simulans (3187) MSCNS | – | Cipro*, levo** | 4.4 |
| 13 | S. lugdunensis (3188) MSCNS | – | Cipro*, levo** | 4.6 |
| 14 | S. liquefaciens (3049) | Amoxicillin/clavulanic acid | – | 1 |
| 15 | S. agalactiae (3050) MLSB (constitutive) | Erythromycin, clindamycin, lincosamides, macrolides, streptogramins b, tetracycline | Levo* | 5.4 |
| 16 | S. agalactiae (3051) MLSB (constitutive) | Erythromycin, clindamycin, lincosamides, macrolides, streptogramins b, tetracycline | Levo* | No data |
| 17 | E. cloacae (3057) | Amoxicillin/clavulanic acid, cipro* | Levo** | > 8 |
| 18 | E. cloacae (3058) | Amoxicillin/clavulanic acid | No data | |
| 19 | E. cloacae (3059) | Amoxicillin/clavulanic acid | No data | |
| 20 | K. aerogenes (3056) | Cefotaxime, fosfomycin i.v | > 8 | |
| 21 | E. faecalis (3066) HLSR | Aminoglycosides, cephalosporins, clindamycin, streptomycin (high level; synergy) | Imipenem | 0.7 |
| 22 | C. koseri (3189) | – | – | 0.4 |
| 23 | C. striatum (3067) | Benzylpenicillin, cipro* | – | 2.4 |
| 24 | C. striatum (3190) | Benzylpenicillin, cipro*, tetracycline | – | No data |
| 25 | K. rhizophila (3065) | – | – | 12 |
| 26 | P. mirabilis (3052) | Gentamicin | Cefuroxime i.v | 2.8 |
| 27 | P. mirabilis (3053) | Ampicillin, fosfomycin i.v., piperacillin/tazobactam, trimethoprim/sulfamethoxazole | Cefuroxime i.v | No data |
| 28 | Proteus mirabilis (3054) | Ampicillin, amoxicillin/clavulanic acid, cefo-taxime, cipro*, trimethoprim/sulfamethoxazole | – | No data |
| 29 | P. penneri (3055) | Amoxicillin/clavulanic acid, cefotaxime, cipro*, trimethoprim/sulfamethoxazole | Levo** | 2.1 |
| 30 | P. penneri (3191) | Amoxicillin/clavulanic acid, cefotaxime, cipro*, trimethoprim/sulfamethoxazole | Levo** | No data |
| 31 | P. monteili (3069) | Cipro*, levo** | Cefepime, ceftazidime, gentamicin, imipenem, piperacillin/azobactam | 2.5 |
| 32 | P. aeruginosa (3070) | – | Imipenem, cefepime, ceftazidime, cipro*, levo**, piperacillin/tazobactam | 1.1 |
PCM numbers are given in parentheses. S. Staphylococcus, C. Corynebacterium. cipro* ciprofloxacin, levo** levofloxacin.